Bedah Kardiotorasik dan Vaskular (Anak)
Penanganan dan Memperbaiki Hemostasis
Obat-obat Antifibrinolitik
Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. (terbuka di window baru)
Sumber: Anesth Analg 2006;102(3):731-7.
Index: PubMed 16492820
DOI: 10.1213/01.ane.0000194954.64293.61
https://www.ncbi.nlm.nih.gov/pubmed/16492820 (terbuka di window baru)
A systematic review of the use of antifibrinolytic agents in pediatric surgery and implications for craniofacial use. (terbuka di window baru)
Sumber: Pediatr Surg Int 2012;28(11):1059-69.
Index: PubMed 22940882
DOI: 10.1007/s00383-012-3167-6
https://www.ncbi.nlm.nih.gov/pubmed/22940882 (terbuka di window baru)
Aprotinin, transfusions, and kidney injury in neonates and infants undergoing cardiac surgery. (terbuka di window baru)
Sumber: Br J Anaesth 2012;108(5):830-7.
Index: PubMed 22362670
DOI: 10.1093/bja/aes002
https://www.ncbi.nlm.nih.gov/pubmed/22362670 (terbuka di window baru)
Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. (terbuka di window baru)
Sumber: J Cardiothorac Vasc Anesth 2004;18(2):141-3.
Index: PubMed 15073700
https://www.ncbi.nlm.nih.gov/pubmed/15073700 (terbuka di window baru)
Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease. (terbuka di window baru)
Sumber: Ann Thorac Surg 2000;70(4):1308-12.
Index: PubMed 11081890
https://www.ncbi.nlm.nih.gov/pubmed/11081890 (terbuka di window baru)
The Bayer 022 compassionate-use pediatric study. (terbuka di window baru)
Sumber: Ann Thorac Surg 1998;65(6 Suppl):S31-3.
Index: PubMed 9647135
https://www.ncbi.nlm.nih.gov/pubmed/9647135 (terbuka di window baru)
Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery. (terbuka di window baru)
Sumber: J Thorac Cardiovasc Surg 2012;143(5):1069-76.
Index: PubMed 22075061
DOI: 10.1016/j.jtcvs.2011.08.051
https://www.ncbi.nlm.nih.gov/pubmed/22075061 (terbuka di window baru)
Minimizing perioperative blood loss and transfusions in children. [Réduire les pertes sanguines et les besoins transfusionnels en chirurgie pédiatrique.] [English, French abstract] (terbuka di window baru)
Sumber: Can J Anaesth 2006;53(6 Suppl):S59-67.
Index: PubMed 16766791
https://www.ncbi.nlm.nih.gov/pubmed/16766791 (terbuka di window baru)
Intraoperative tranexamic acid in pediatric bloodless cardiac surgery. (terbuka di window baru)
Sumber: Asian Cardiovasc Thorac Ann 2014;22(9):1039-45.
Index: PubMed 24637029
DOI: 10.1177/0218492314527991
https://www.ncbi.nlm.nih.gov/pubmed/24637029 (terbuka di window baru)
The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery. (terbuka di window baru)
Sumber: PLoS One 2015;10(5):e0126514.
Index: PubMed 25954976
DOI: 10.1371/journal.pone.0126514
https://www.ncbi.nlm.nih.gov/pubmed/25954976 (terbuka di window baru)
Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials. (terbuka di window baru)
Sumber: Int J Clin Exp Pathol 2015;8(7):7978-87.
Index: PubMed 26339364
https://www.ncbi.nlm.nih.gov/pubmed/26339364 (terbuka di window baru)
Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery. (terbuka di window baru)
Sumber: Eur J Cardiothorac Surg 2011;39(6):892-7.
Index: PubMed 21115357
DOI: 10.1016/j.ejcts.2010.09.041
https://www.ncbi.nlm.nih.gov/pubmed/21115357 (terbuka di window baru)
Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome. (terbuka di window baru)
Sumber: Br J Anaesth 2013;110(4):615-21.
Index: PubMed 23213034
DOI: 10.1093/bja/aes430
https://www.ncbi.nlm.nih.gov/pubmed/23213034 (terbuka di window baru)
Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. (terbuka di window baru)
Sumber: Ann Thorac Surg 1998;66(2):535-40; discussion 541.
Index: PubMed 9725399
https://www.ncbi.nlm.nih.gov/pubmed/9725399 (terbuka di window baru)
Efficacy of tranexamic acid as compared to aprotinin in open heart surgery in children. (terbuka di window baru)
Sumber: Ann Card Anaesth 2015;18(1):23-6.
Index: PubMed 25566706
DOI: 10.4103/0971-9784.148316
https://www.ncbi.nlm.nih.gov/pubmed/25566706 (terbuka di window baru)
Comparative analysis of antifibrinolytic medications in pediatric heart surgery. (terbuka di window baru)
Sumber: J Thorac Cardiovasc Surg 2012;143(3):550-7.
Index: PubMed 22264414
DOI: 10.1016/j.jtcvs.2011.06.048
https://www.ncbi.nlm.nih.gov/pubmed/22264414 (terbuka di window baru)
The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. (terbuka di window baru)
Sumber: Anesth Analg 1997;84(5):990-6.
Index: PubMed 9141920
https://www.ncbi.nlm.nih.gov/pubmed/9141920 (terbuka di window baru)
Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study. (terbuka di window baru)
Sumber: Eur J Anaesthesiol 2015;32(12):844-50.
Index: PubMed 26258658
DOI: 10.1097/EJA.0000000000000316
https://www.ncbi.nlm.nih.gov/pubmed/26258658 (terbuka di window baru)
Comparison of different doses of ε-aminocaproic acid in children for tetralogy of Fallot surgery: clinical efficacy and safety. (terbuka di window baru)
Sumber: J Cardiothorac Vasc Anesth 2013;27(1):23-9.
Index: PubMed 22995453
DOI: 10.1053/j.jvca.2012.07.001
https://www.ncbi.nlm.nih.gov/pubmed/22995453 (terbuka di window baru)
Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation. (terbuka di window baru)
Sumber: Ann Card Anaesth 2010;13(2):110-5.
Index: PubMed 20442540
DOI: 10.4103/0971-9784.62935
https://www.ncbi.nlm.nih.gov/pubmed/20442540 (terbuka di window baru)
Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass. (terbuka di window baru)
Sumber: Anesthesiology 2015;122(4):746-58.
Index: PubMed 25585004
DOI: 10.1097/ALN.0000000000000570
https://www.ncbi.nlm.nih.gov/pubmed/25585004 (terbuka di window baru)
Efficacy and safety of aprotinin in neonatal congenital heart operations. (terbuka di window baru)
Sumber: Ann Thorac Surg 2011;92(3):958-63.
Index: PubMed 21871283
DOI: 10.1016/j.athoracsur.2011.04.094
https://www.ncbi.nlm.nih.gov/pubmed/21871283 (terbuka di window baru)
The effect of preoperative tranexamic acid on blood loss after cardiac operations in children. (terbuka di window baru)
Sumber: J Thorac Cardiovasc Surg 1996;111(5):982-7.
Index: PubMed 8622323
https://www.ncbi.nlm.nih.gov/pubmed/8622323 (terbuka di window baru)
Rekombinan Faktor VII yang Diaktivasi (rFVIIa)
Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery. (terbuka di window baru)
Sumber: Ann Thorac Surg 2007;84(1):161-8.
Index: PubMed 17588404
DOI: 10.1016/j.athoracsur.2007.02.051
https://www.ncbi.nlm.nih.gov/pubmed/17588404 (terbuka di window baru)
Pediatric off-label use of recombinant factor VIIa. (terbuka di window baru)
Sumber: Pediatrics 2009;123(3):1066-72.
Index: PubMed 19255041
DOI: 10.1542/peds.2008-1685
https://www.ncbi.nlm.nih.gov/pubmed/19255041 (terbuka di window baru)
Factor VII for excessive bleeding following congenital heart disease surgery. (terbuka di window baru)
Sumber: Asian Cardiovasc Thorac Ann 2012;20(2):120-5.
Index: PubMed 22499956
DOI: 10.1177/0218492311433614
https://www.ncbi.nlm.nih.gov/pubmed/22499956 (terbuka di window baru)
Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. (terbuka di window baru)
Sumber: Paediatr Anaesth 2009;19(4):364-70.
Index: PubMed 19143947
DOI: 10.1111/j.1460-9592.2008.02905.x
https://www.ncbi.nlm.nih.gov/pubmed/19143947 (terbuka di window baru)
Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients. (terbuka di window baru)
Sumber: Anesth Analg 2012;115(2):364-78.
Index: PubMed 22652310
DOI: 10.1213/ANE.0b013e31825aff10
https://www.ncbi.nlm.nih.gov/pubmed/22652310 (terbuka di window baru)
Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery? (terbuka di window baru)
Sumber: Interact Cardiovasc Thorac Surg 2012;15(4):690-4.
Index: PubMed 22811512
DOI: 10.1093/icvts/ivs309
https://www.ncbi.nlm.nih.gov/pubmed/22811512 (terbuka di window baru)
Cardiac surgery without blood products in a Jehovah's Witness child with factor VII deficiency. (terbuka di window baru)
Sumber: J Cardiothorac Vasc Anesth 2012;26(4):651-3.
Index: PubMed 21924639
DOI: 10.1053/j.jvca.2011.07.012
https://www.ncbi.nlm.nih.gov/pubmed/21924639 (terbuka di window baru)
Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. (terbuka di window baru)
Sumber: J Cardiothorac Vasc Anesth 2011;25(6):987-94.
Index: PubMed 21835642
DOI: 10.1053/j.jvca.2011.05.012
https://www.ncbi.nlm.nih.gov/pubmed/21835642 (terbuka di window baru)
Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery. (terbuka di window baru)
Sumber: J Clin Anesth 2014;26(3):204-11.
Index: PubMed 24809789
DOI: 10.1016/j.jclinane.2013.10.015
https://www.ncbi.nlm.nih.gov/pubmed/24809789 (terbuka di window baru)
Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery. (terbuka di window baru)
Sumber: Asian Cardiovasc Thorac Ann 2012;20(1):19-23.
Index: PubMed 22371937
DOI: 10.1177/0218492311432584
https://www.ncbi.nlm.nih.gov/pubmed/22371937 (terbuka di window baru)
Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant. (terbuka di window baru)
Sumber: Pediatr Crit Care Med 2003;4(1):49-51.
Index: PubMed 12656542
DOI: 10.1097/01.PCC.0000031472.55687.4E
https://www.ncbi.nlm.nih.gov/pubmed/12656542 (terbuka di window baru)
Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients. (terbuka di window baru)
Sumber: J Intensive Care Med 2004;19(5):270-3.
Index: PubMed 15358945
DOI: 10.1177/0885066604267783
https://www.ncbi.nlm.nih.gov/pubmed/15358945 (terbuka di window baru)
Recombinant activated factor VII in cardiac surgery: a systematic review. (terbuka di window baru)
Sumber: Ann Thorac Surg 2007;83(2):707-14.
Index: PubMed 17258029
DOI: 10.1016/j.athoracsur.2006.10.033
https://www.ncbi.nlm.nih.gov/pubmed/17258029 (terbuka di window baru)
Defining the role of recombinant activated factor VII in pediatric cardiac surgery: where should we go from here? (terbuka di window baru)
Sumber: Pediatr Crit Care Med 2009;10(5):572-82.
Index: PubMed 19451849
DOI: 10.1097/PCC.0b013e3181a642d5
https://www.ncbi.nlm.nih.gov/pubmed/19451849 (terbuka di window baru)
Decreasing the need for transfusion: infant cardiac surgery using hemodilution and recombinant factor VIIa. (terbuka di window baru)
Sumber: Pediatr Cardiol 2013;34(1):119-24.
Index: PubMed 22760694
DOI: 10.1007/s00246-012-0398-1
https://www.ncbi.nlm.nih.gov/pubmed/22760694 (terbuka di window baru)
Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. (terbuka di window baru)
Sumber: Pediatr Hematol Oncol 2008;25(4):301-11.
Index: PubMed 18484474
DOI: 10.1080/08880010802016904
https://www.ncbi.nlm.nih.gov/pubmed/18484474 (terbuka di window baru)
Konsentrat Faktor Koagulan
Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (terbuka di window baru)
Sumber: Artif Organs 2010;34(11):955-60.
Index: PubMed 21092037
DOI: 10.1111/j.1525-1594.2010.01148.x
https://www.ncbi.nlm.nih.gov/pubmed/21092037 (terbuka di window baru)
Plasma fibrinogen concentration is correlated with postoperative blood loss in children undergoing cardiac surgery. A retrospective review. (terbuka di window baru)
Sumber: Eur J Anaesthesiol 2014;31(6):317-26.
Index: PubMed 24503704
DOI: 10.1097/EJA.0000000000000043
https://www.ncbi.nlm.nih.gov/pubmed/24503704 (terbuka di window baru)
Efficacy and safety of fibrinogen concentrate in surgical patients: a meta-analysis of randomized controlled trials. (terbuka di window baru)
Sumber: J Cardiothorac Vasc Anesth 2016;30(5):1196-204.
Index: PubMed 27493092
DOI: 10.1053/j.jvca.2016.04.015
https://www.ncbi.nlm.nih.gov/pubmed/27493092 (terbuka di window baru)
Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial. (terbuka di window baru)
Sumber: J Thorac Cardiovasc Surg 2014;148(4):1647-55.
Index: PubMed 24951020
DOI: 10.1016/j.jtcvs.2014.04.029
https://www.ncbi.nlm.nih.gov/pubmed/24951020 (terbuka di window baru)
Four-factor prothrombin complex concentrates in paediatric patients—a retrospective case series. (terbuka di window baru)
Sumber: Vox Sang 2016;110(3):253-7.
Index: PubMed 26509839
DOI: 10.1111/vox.12353
https://www.ncbi.nlm.nih.gov/pubmed/26509839 (terbuka di window baru)
Desmopressin
Minimizing perioperative blood loss and transfusions in children. [Réduire les pertes sanguines et les besoins transfusionnels en chirurgie pédiatrique.] [English, French abstract] (terbuka di window baru)
Sumber: Can J Anaesth 2006;53(6 Suppl):S59-67.
Index: PubMed 16766791
https://www.ncbi.nlm.nih.gov/pubmed/16766791 (terbuka di window baru)
Anesthetic management in a pediatric patient with Noonan syndrome, mastocytosis, and von Willebrand disease: a case report. (terbuka di window baru)
Sumber: AANA J 2007;75(4):261-4.
Index: PubMed 17711156
https://www.ncbi.nlm.nih.gov/pubmed/17711156 (terbuka di window baru)
Obat-obat Hemostatik Topikal
A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. (terbuka di window baru)
Sumber: Ann Surg 2010;251(2):217-28.
Index: PubMed 20010084
DOI: 10.1097/SLA.0b013e3181c3bcca
https://www.ncbi.nlm.nih.gov/pubmed/20010084 (terbuka di window baru)
Resternotomy in pediatric cardiac surgery: CoSeal initial experience. (terbuka di window baru)
Sumber: Interact Cardiovasc Thorac Surg 2007;6(1):21-3.
Index: PubMed 17669759
DOI: 10.1510/icvts.2006.141531
https://www.ncbi.nlm.nih.gov/pubmed/17669759 (terbuka di window baru)
Tes Viskoelaktik untuk Mencari Perdarahan dalam Bedah atau Koagulopati
Utility of Sonoclot analysis and tranexamic acid in tetralogy of Fallot patients undergoing intracardiac repair. (terbuka di window baru)
Sumber: Ann Card Anaesth 2012;15(1):26-31.
Index: PubMed 22234018
DOI: 10.4103/0971-9784.91477
https://www.ncbi.nlm.nih.gov/pubmed/22234018 (terbuka di window baru)
Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (terbuka di window baru)
Sumber: Artif Organs 2010;34(11):955-60.
Index: PubMed 21092037
DOI: 10.1111/j.1525-1594.2010.01148.x
https://www.ncbi.nlm.nih.gov/pubmed/21092037 (terbuka di window baru)
Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. (terbuka di window baru)
Sumber: Br J Anaesth 2015;114(1):91-102.
Index: PubMed 25303988
DOI: 10.1093/bja/aeu339
https://www.ncbi.nlm.nih.gov/pubmed/25303988 (terbuka di window baru)